Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

How Is America’s Food System Responding to the COVID-19 Pandemic?


News Image

As the Coronavirus and COVID-19 spread quickly, so is the panic in our own grocery stores. So is the United States Food Supply Chain enough to manage the nationwide anxiety?

AAEA members Trey Malone and Alek Schaefer from Michigan State University are hosting a public livestreaming event Friday, March 27 at 3 pm – 4 pm to answer questions live about economic uncertainty in the food supply chain during the threat of the novel coronavirus.

Malone says he is confident that as long as there is a demand for food, the U.S. supply chain will be more than capable of providing for its consumers.

“At least from my perspective in the current moment, markets are responding to uncertainty more than they are actual cases, and people are updating their prior beliefs as time moves on…An explosion in the number of sicknesses would clearly pose a problem, but one of the truths of economics is that – so long as markets are allowed to work – there will be some supply for what people demand. Look no further than the way 3M will produce more than a billion masks by the end of 2020!” Malone says.

He continues, “I know this seems crazy, but price increases mean that the market is working… I would be more concerned if I didn’t see price responses as that would imply that we aren’t operating in a market system anymore. The flip side to that is that businesses who think long-run shouldn’t be gouging their customers in their time of need, and there is a fine line between market responses and price gouging in a world where people are scared. I need to be abundantly clear that we are all a part of the same team right now, and bad behavior truly has the potential to put the most vulnerable among us in the most severe risk.

If you are interested in attending the livestream Zoom event, visit: https://msu.zoom.us/j/812284181.

March 27, 2020

3:00PM – 4:00PM EST

ABOUT AAEA: Established in 1910, the Agricultural & Applied Economics Association (AAEA) is the leading professional association for agricultural and applied economists, with 2,500 members in more than 60 countries. Members of the AAEA work in academic or government institutions as well as in industry and not-for-profit organizations, and engage in a variety of research, teaching, and outreach activities in the areas of agriculture, the environment, food, health, and international development. The AAEA publishes two journals, the American Journal of Agricultural Economics and Applied Economic Perspectives & Policy, as well as the online magazine Choices and the online open access publication series Applied Economics Teaching Resources. To learn more, visit http://www.aaea.org.

Share article on social media or email:

Sterling Healthcare is launching its HealthFIN Revenue & Clinical Audit service at no charge to eligible hospitals and provider groups impacted by COVID-19


Sterling Healthcare’s Center of Excellence continues its momentum with the launch of HealthFIN an analytics-powered, auditing service. The novel coronavirus pandemic is causing hospitals and provider groups to face an unprecedented surge in acute patient care needs. Besides the human factor, hospitals are also facing a new financial crisis with vendors not updating their systems with the current coronavirus diagnostic, testing, procedural, and treatment codes from CMS. The HealthFIN Revenue Cycle audit service can provide accurate feedback to government agencies, providers, and hospitals by identifying gaps and errors in typical vendor systems.

David Osborn, Sterling Healthcare’s Managing Director, and Healthcare Practice Leader, stated, “identifying and resolving such critical issues will give accurate and updated insights beyond what the current market is providing today.”

Key features of the audit take into consideration inaccurate COVID-19 coding and reporting, claim denials, bad-debt write-offs, underpayments, and clean claim percentage. HealthFIN also addresses the latest COVID-19 telehealth coding and billing best-practices to protect healthcare workers. The economic reality of the CORVID-19 pandemic will require healthcare providers to explore innovative strategies to improve back-end revenue optimization.

To support the U.S. healthcare industry, Sterling Healthcare is waiving initial fees with the HealthFIN Revenue Cycle Audit service to eligible hospitals or healthcare providers for the next six months. Results from the HealthFIN service can deliver a prescriptive remediation plan to advance the provider’s business.

Now, reimagining the revenue cycle means identifying potential RCM deficiencies while COVID-19 cases continue to climb here in the United States. Sterling Healthcare will continue to strengthen our hospital and provider groups afflicted by the coronavirus epidemic.

About Sterling Healthcare Services:

For the past twenty years, Sterling Healthcare Services, headquartered in Louisville, KY, has provided cloud-based financial and clinical optimization services to hospitals, specialty providers, and managed care organizations. Sterling is a subsidiary of Elico, a 60-year-old global biomedical device manufacturer. Together, we continuously improve our capabilities in our Center of Excellence to enhance the quality of healthcare.

For additional information, see: SterlingHCS.com or contact Public Relations Agency, MindFlash International Inc at 1.800.430.8754

Share article on social media or email:

Dr. Michael Omidi Partners with the Exclusive Haute Beauty Network


During his 15-year career, Dr. Omidi has performed thousands of face, nose, breast and, body procedures, enabling his patients to live happier, more fulfilled lives.

Dr. Michael Omidi, M.D., F.A.C.S. is a double-board certified plastic surgeon practicing in Beverly Hills and the Greater Los Angeles area. During his 15-year career, Dr. Omidi has performed thousands of face, nose, breast and, body procedures, enabling his patients to live happier, more fulfilled lives. Always at the cutting edge of new developments in the field of cosmetic surgery, Dr. Omidi is known for fine-tuning his procedures and techniques to achieve exceptional results while maintaining his focus on optimal patient safety. He has built a reputation for consistently delivering excellent results through combining safe surgical and non-surgical modalities such as lasers and radiofrequency procedures that promote faster recovery and allow his patients to return to their lives more quickly and with less pain.

Dr. Omidi’s background as a board-certified breast and abdominal surgeon has given him first-hand access to advanced techniques in breast and body contouring. He is one of the few plastic surgeons that has undertaken advanced training in facial and nose contouring surgery. Because of this, Dr. Omidi is sought out by patients from around the world to perform these complex nose, eyelid and face surgeries.

Dr. Michael Omidi’s peers and patients alike have repeatedly rated him as one of the top plastic surgeons in Southern California. He has been ranked as the top plastic surgeon in Beverly Hills by RateMDs for three consecutive years and was named the best Breast Augmentation and Rhinoplasty Doctor by Cosmetic Town Journal. He was also featured in the hit E! reality television series Dr. 90210 where he helped a woman get a new outlook on life through her augmentation. Dr. Omidi’s down-to-earth approach to his patients involves taking the time to listen to each patient and work together to identify their exact needs and desires. His unassuming demeanor enables him to easily build rapport with his patients, many of whom consider him a friend. Regardless of their background, Dr. Omidi takes pride in providing thoughtful, compassionate care for every patient and procedure he performs.

Outside of his professional life, Dr. Omidi personally organizes and finances his own team of doctors and nurses for pro bono international missions to Vietnam, Philippines and Colombia where they have treated more than 1,500 patients with pediatric deformities, burns, cleft lips/palates, head/neck tumors, and breast cancers. He has also undertaken surgical missions to the Philippines and Colombia where he taught and trained local surgeons. Dr. Omidi has been named one of America’s Most Honored Professionals five years in a row (2016-2020) recognizing him as being in the top 1% of healthcare professionals in the United States. He has also received the Vitals Compassionate Doctor award in recognition of being one of the top 10 plastic surgeons in Beverly Hills.

Some of Dr. Omidi’s notable accomplishments include being a Magna Cum Laude graduate from Cal State University and graduating with distinction in research from the St. Louis University School of Medicine. Dr. Omidi has served as an Instructor of Surgery at the prestigious Northwestern University Hospital in Chicago and served as the Chief Resident at both Northwestern University Hospital and the University of Medicine in Newark, NJ. He has extensive specialized training in facial cosmetic, pediatric and craniofacial reconstructive surgery from Miami Children’s Hospital. Dr. Omidi maintains his board certification from the American Board of Plastic Surgery, American Board of Surgery, is a fellow of the American College of Surgeons and is a member of the American Society of Maxillofacial Surgery, American Society of Plastic Surgery and International Society of Aesthetic Plastic Surgery.

Share article on social media or email:

Mediaplanet and Dr. Mark Hyman Team Up to raise awareness about the link between lifestyle and chronic diseases


News Image

This campaign will serve as a resource for Americans who are seeking treatment options for chronic diseases such as cardiovascular disease.

Helping to conclude National Nutrition Month, Mediaplanet today announces the launch of the first-ever edition of “Nutrition and Heart Health.” This campaign will serve as a resource for Americans who are seeking treatment options for chronic diseases such as cardiovascular disease. It will also educate healthcare professionals and patients on current trends in cardiovascular treatment and technology.

The print component of “Nutrition and Heart Health” is distributed within today’s edition of USA Today in Los Angeles, San Francisco, New York, Altanta, Nashville, Houston, Dallas, D.C., and Chicago markets, with a circulation of approximately 200,000 copies and an estimated readership of 600,000. The digital component is distributed nationally, through a vast social media strategy, and across a network of top news sites and partner outlets. To explore the digital version of the campaign, visit:

Physician and New York Times best-selling author Dr. Mark Hyman graces the cover of the print publication. Through an exclusive interview on the interior, Dr. Hyman talks about the benefits of eating a plant-rich diet, and what the modern healthy diet should consist of, despite outdated government recommendations. “Instead of demonizing one macronutrient like fat or carbs, I recommend that we just stick to real, whole foods, not food-like substances,” says Hyman.

Other editorials in the campaign include plant-based healthcare, a new trend across healthcare professionals and patients that’s using the power of plants to aid in disease treatment, careers in nutrition, advancements in cardiovascular disease treatment and technology, congenital heart defects and pediatric cardiology, and the future of personalized healthcare.

This campaign was made possible with the support of Greenleaf Foods, WeTheTrillions, University of Southern California Leonard Davis School of Gerontology, American Heart Association, Blossom Bariatrics, DNALife, GrassrootsHealth Nutrient Research Institute, Johns Hopkins Children’s Hospital, The Sugar Association, Children’s Heart Foundation, and the American Society of Nuclear Cardiology.

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Press Contact:

Shannon Ruggiero

6467557962

Share article on social media or email:

Fitscript Offering GlucoseZone, Digital Exercise Treatment for Diabetics, for Free During COVID-19 Emergency


News Image

Fitscript LLC, a Connecticut venture-backed company helping people living with diabetes meet exercise requirements, today announced that the company is offering its digital therapeutic product, GlucoseZone, for free to any person living with diabetes during the COVID-19 emergency. GlucoseZone is the first patented and clinically validated digital therapy proven to use exercise to help people with diabetes maintain healthy weight and lower their A1c levels.

Access to safe and effective exercise is especially critical for people with diabetes during the pandemic, as people with diabetes are at higher risk from coronavirus than the general population. GlucoseZone makes it possible for them to safely and effectively exercise at home.

“GlucoseZone was created for people living with diabetes as a way to ensure they can get the safe and effective exercise they need wherever they are located,” said Charlie O’Connell, founder of GlucoseZone and patient entrepreneur. “For this reason, we are providing GlucoseZone for free to people living with diabetes who can’t get access to gyms and fitness centers during this COVID-19 emergency. Diabetes doesn’t stop for coronavirus, and people with diabetes need to maintain their fitness and be even more vigilant during this time.”

The GlucoseZone program is the first digital exercise solution that offers guidance, support and coaching based on the user’s individual requirements, including their real-time glucose levels and other biometric data captured from wearable devices such as glucose meters, insulin pumps and heart rate monitors. GlucoseZone enables people living with diabetes to incorporate exercise wherever they are and at whatever stage of their disease, and represents an important step in making affordable, real-time exercise support accessible using digital technology.

Fitscript is a Connecticut Innovations portfolio company that provides GlucoseZone to major health plans, providers and payers in the state, including the State of Connecticut’s Health Enhancement Program (HEP), the City of New Haven, Yale New Haven Health System, Griffin Health, ConnectiCare and others.

Diabetes and prediabetes impact the lives and health of more than 114 million Americans. GlucoseZone’s content has been accessed by millions of users around the world.

About GlucoseZone by Fitscript LLC:

Created in 2012, Fitscript LLC was founded to help people living with diabetes meet the exercise requirement for safely and effectively reducing and controlling their diabetes. Fitscript’s patented, proprietary GlucoseZone program, now with more than 1 million users, is the first-ever digital exercise solution for people with diabetes that helps improve their A1c levels and achieve weight loss based on real-time glucose levels. The GlucoseZone app contains live and on-demand exercise solutions, interactive workouts, diabetes discussions and much more. The app is available on iOS and Android. To learn more about GlucoseZone, please visit http://www.glucosezone.com. Connect with GlucoseZone’s social media channels: http://www.youtube.com/GlucoseZone and http://www.facebook.com/glucosezone.

Share article on social media or email:

Dr. Samuel Lin Continues Partnership with the Exclusive Haute Beauty Network


Dr. Lin is board certified by both the American Board of Plastic Surgery and the American Board of Otolaryngology-Head and Neck Surgery.

Dr. Samuel Lin a renowned nose expert in the Boston market, is continuing his partnership with the esteemed Haute Beauty Network.

The Haute Beauty Network, well known for its exclusive and luxurious lifestyle publication Haute Living, is privileged to continue its partnership with Dr. Samuel Lin as Boston plastic suregeon and a partner of the Haute Beauty members-only network.

Haute Beauty offers a prominent collective of leading doctors. The invitation-only exclusive publication maintains elite as ever, with only two doctors in every market. This partnership allows Haute Beauty to connect its affluent readers with industry-leading aesthetic surgeons located in their area.

Visit Dr. Lin’s Haute Beauty profile: https://hauteliving.com/hautebeauty/member/samuel-lin/

ABOUT DR. SAMUEL LIN:

Dr. Samuel Lin is a double board certified Plastic Surgeon and Associate Professor of Surgery at Harvard Medical School who practices in Boston, Massachusetts. Dr. Lin received his Bachelor’s degree in Biomedical Engineering at Northwestern University and was enrolled in the Honors Program for Medical Education at Northwestern University, Feinberg School of Medicine, Chicago, Illinois. He then completed a five-year-residency in Otolaryngology-Head and Neck Surgery followed by a three-year-residency in Plastic and Reconstructive Surgery at Northwestern Memorial Hospital. This was followed by a one-year fellowship appointment in Microvascular Reconstructive Surgery at the world-renowned University of Texas M.D. Anderson Cancer Center in Houston, Texas. Throughout the course of his training, Dr. Lin gained state-of-the-art skills in a multitude of reconstructive and cosmetic procedures with his background in Head and Neck Surgery providing him with additional expertise in Plastic and Reconstructive Surgery.

Dr. Lin is board certified by both the American Board of Plastic Surgery and the American Board of Otolaryngology-Head and Neck Surgery. For all physicians who train in the United States, the American Board of Medical Specialties (ABMS) is the gold standard for physician certification in the United States and has only 24-member boards. Dr. Lin is board certified by two ABMS boards. He is Program Director of the BIDMC-Harvard Plastic and Reconstructive Surgery residency, and Co-Director of the Harvard Aesthetic and Reconstructive Plastic Surgery Fellowship at BIDMC. He serves as an Associate Editor on the Editorial board for Plastic and Reconstructive Surgery, the main journal for plastic surgery. Dr. Lin, his team, and his collaborators regularly publish scientific papers in the literature to further knowledge about plastic surgery and other topics. Dr. Lin is an active Board Member of the Susan G. Komen for the Cure and Bright Pink Foundations. Dr. Lin is active in both basic science and clinical research with a focus on face/neck/nose surgery (rhinoplasty), breast surgery (reduction, lift and reconstruction), and body contouring. He collaborates with engineers, scientists, and other plastic surgeons at other institutions within the New England area, nationally, and internationally. He is the editor of several medical textbooks including Aesthetic Atlas of the Head and Neck, Atlas of Body Contouring, and Plastic and Reconstructive Surgery Pearls of Wisdom and Pearls of Wisdom Second and Third Editions. He was recently awarded the American Association of Plastic Surgeons (AAPS) Academic Scholar Award. Dr. Lin is committed to mentoring both medical students, residents, and fellows (national and international) who rotate in the Division of Plastic Surgery at BIDMC. For his efforts, Dr. Lin was awarded the recipient of a “Mentoring Award,” by Harvard Medical School through a special nomination process which is sent out to all Harvard faculty members, house officers, fellows and students. He has been a Boston “Top Doc” for several years in plastic surgery.

Share article on social media or email:

LabRoots Takes Action Through its Coronavirus Online Webinar Series to Provide Educational Discussions Surrounding the Disease, scheduled on April 2, 2020


News Image

LabRoots, the leading scientific social networking website offering premier, interactive virtual events and webinars, will be hosting approximately over 12,000 physicians, researchers, health educators, pharmacists, clinicians, scientists and industry and academia professionals who are committed to learning current information on implementing infection prevention and control measures and assessing risks for exposures about Coronavirus (COVID-19). The first Coronavirus Webinar of the ongoing series commences on April 2nd, offering guidance and emerging developments regarding the evolving COVID-19 pandemic.

Kicking off the free Coronavirus Virtual Webinar Series, the event will feature an impressive agenda of recognized leaders who will present on topics covering, the origins and symptoms of COVID-19, laboratory tests in COVID-19 diagnosis and treatment, and the containment of COVID-19 cases.

Highlighting “Specimen Collection and Laboratory Safety,” a panel of five renowned experts with diverse backgrounds will examine specifically how samples are collected and processed to be tested in reference laboratories, best practices in collecting respiratory (swab) specimens and the effective protection for sampling staff, protection for laboratory professionals when handling blood, urine, stool and respiratory specimens, next-generation sequencing as it plays a significant role in the diagnosis, and the utility of nucleic acid and antibody tests as it relates to the importance of sampling locations and clinical sensitivity.

This full day of cutting-edge presentations delivered by prominent speakers also spans important areas encompassing laboratory diagnosis of Wuhan SARS-CoV-2 infections: current status to review the current laboratory methods available and random-access, point-of-care molecular devices for rapid and accurate diagnosis – such assays can be used in the local hospitals and clinics bearing the burden of identifying and treating patients; a session introduced by Li Jiang, MD, PHD, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital and Center for Clinical Laboratories (SPCCL) on the implementation of molecular diagnostics for SARS-CoV-2; and a SARS-CoV-2 (COVID-19: Emergence, Biology, and Countermeasures) presentation shared by Dr. Mark Denison, Director, Division of Infectious Diseases, Craig-Weaver Professor of Pediatrics, Professor of Pathology, Microbiology & Immunology, at Vanderbilt University round out the program.

Greg Cruikshank, Chief Executive Officer of LabRoots said, “The emergence and rapid increase in cases of Coronavirus disease 2019 (COVID-19) continue to cause complex challenges to global public health. Through our collaborative platform, we are excited to continue our strong foothold and presence in the online virtual conference arena to positively impact the scientific community. By offering an educational forum to the world, attendees of our newly added Coronavirus Webinar Series can be further prepared for COVID-19 by learning more about the need for prompt diagnosis, robust research, and understanding of biology and science to develop effective countermeasures,” added Cruikshank.

Produced on LabRoots’ robust platform, this online environment with exhibit and poster halls, and networking lounge allows attendees to connect seamlessly across all desktop and mobile devices. By participating in this webinar series, you can earn 1 Continuing Education credit per presentation.

For more information or to register for the event, click here. Participants can follow the conversation online by using #LRcoronavirus.

About LabRoots

LabRoots is the leading scientific social networking website, and primary source for scientific trending news and premier educational virtual events and webinars and more. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Founded in 2008, LabRoots emphasizes digital innovation in scientific collaboration and learning. Offering more than articles and webcasts that go beyond the mundane and explore the latest discoveries in the world of science, LabRoots users can stay atop their field by gaining continuing education credits from a wide range of topics through their participation in the webinars and virtual events.

Share article on social media or email:

Dr. Timothy Katzen Partners with the Exclusive Haute Beauty Network


Award-winning and board-certified plastic surgeon Dr. J. Timothy Katzen is proud to offer a comprehensive range of aesthetic procedures to women and men at his esteemed facilities in Beverly Hills, CA and Las Vegas, NV.

The Haute Beauty Network, well known for its exclusivity, and luxurious lifestyle, is privileged to present Dr. Timothy Katzen as a leading weight-loss and Body expert representing the Los Angeles Market and the newest addition to the Haute Living partnership.

Haute Beauty offers a prominent collective of leading doctors nationwide. The invitation-only exclusive network maintains elite as ever, with only two doctors in every market. This partnership allows Haute Beauty to connect its affluent readers with industry-leading doctors.

Visit Dr. Katzen’s Haute Beauty Profile: https://hauteliving.com/hautebeauty/member/dr-timothy-katzen/

About Dr. Katzen:

Award-winning and board-certified plastic surgeon Dr. J. Timothy Katzen is proud to offer a comprehensive range of aesthetic procedures to women and men at his esteemed facilities in Beverly Hills, CA and Las Vegas, NV. Having been featured on a number of television programs, such as TLC’s The Real Skinny and Discovery Health’s The Incredible Shrinking Woman, he has gained recognition for his advanced after weight loss surgery techniques. The most notable of these techniques is his trademark 360 circumferential body lift, which he has performed for numerous patients to help them fully realize their post-weight loss body goals. Dr. Katzen cares deeply for each of his charges and actively involves them in the decision-making process of their personalized surgical treatment plans. This is to ensure that their unique concerns are addressed and goals met.

In addition to weight loss procedures, Dr. Katzen specializes in silicone injection removal, thigh and arm reduction, breast augmentation, breast lift, Vaser High Definition Liposuction and facelifts.

Share article on social media or email:

NeoTract Designates Dr. Harpreet Wadhwa as UroLift® Center of Excellence


News Image

“We are proud to name Dr. Harpreet Wadhwa as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that Harpreet Wadhwa, M.D., East Valley Urology Center in Mesa, AZ has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Wadhwa has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“We are proud to name Dr. Harpreet Wadhwa as a UroLift Center of Excellence and provider of care for men with enlarged prostate symptoms using the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit. “The UroLift System is a safe and effective treatment that allows physicians to treat men in-office under local anesthesia, so they can experience lasting symptom relief within days after receiving treatment.”

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated:

Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504 nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2.McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

Talos Health Solutions Partners with AstraZeneca Pharmaceuticals to Educate Asthma Patients


illustration of a lung

According to the Centers for Disease Control and Prevention, 1 in 13 people has asthma. This means more than 26 million Americans suffer from this disease.

Understanding my disease better and knowing my early warning signals helped me to reduce my hospitalizations from two per year to almost zero. Knowledge had a direct impact on my quality of life.

On March 27th, 2020, Talos Health Solutions, kicked off AsthmaCon 2020, a three-month online educational health conference for people with asthma, their families and caregivers living in the US. This free online conference will be available to the public 24-hours a day between March 27, 2020 and June 30, 2020, and will focus on asthma symptoms, the different kinds of asthma, treatment options, the experience of other patients and much more. Attendees will hear from respiratory experts including as well as patient advocates and patients themselves living with asthma. Attendees can register and participate in this online health conference by logging into https://asthmacon.com.

“Understanding my disease better and knowing my early warning signals helped me to reduce my hospitalizations from two per year to almost zero. Knowledge had a direct impact on my quality of life,” stated Mitchell Silva, a patient expert.

Virtual health conferences like AsthmaCon 2020 are an innovative way of sharing educational information with patients and caregivers, allowing participants to digest the material online over a three month period, hear from all of the speakers, download information, and return to the conference on their own schedules, in the comfort of their homes. There is no fee to participate.

AsthmaCon 2020 is an AstraZeneca Pharmaceuticals initiative in partnership with The American Allergy and Asthma Network (AAN), the Global Allergy and Asthma Patient Platform (GAAPP), the Asthma and Allergy Foundation of America (AAFA) and Talos Health Systems.

For more information, or to register for AsthmaCon 2020, visit online at https://asthmacon.com.

Share article on social media or email: